News in the Life Sciences Industry

BOSTON and STOCKHOLM, Aug. 5, 2019 /PRNewswire/ -- Aprea Therapeutics, a clinical-stage biotechnology company focused on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein, today announced the appointment of Scott Coiante as Senior Vice... Read more ››

JOENSUU, Finland, Aug. 5, 2019 /PRNewswire/ -- Eating rye comes with a variety of health benefits. A new study from the University of Eastern Finland now shows that both lactic acid bacteria and gut bacteria contribute to the health benefits of rye. Published in Microbiome, the study... Read more ››

STOCKHOLM, Aug. 2, 2019 /PRNewswire/ -- Cyxone (publ), a Swedish biotech in autoimmune diseases, today announced that the clinical phase I trial with drug candidate T20K successfully achieved its purpose of confirming T20K's safety and tolerability in humans. There were no reports of serious... Read more ››

LUND, Sweden, July 31, 2019 /PRNewswire/ -- BioInvent International AB ("BioInvent" or the "Company") (OMXS: BINV) today announces that Pfizer Inc. ("Pfizer") (NYSE: PFE) has selected the first target under the companies' cancer immunotherapy research collaboration and license Read more ››

STOCKHOLM, July 31, 2019 /PRNewswire/ -- This summer marks the ten-year anniversary since the first order of the treatment planning system RayStation. The first customer was the proton center Westdeutsches Protonentherapie-zentrum Essen (WPE) in Germany. Ten years later, RayStation is established... Read more ››

STOCKHOLM, July 31, 2019 /PRNewswire/ -- Q-linea AB (publ) ("Q-linea" or "the Company"), today announced that the number of shares and votes in Q-linea has increased during the month of July due to the new share issue carried out to ensure delivery of performance shares within the framework... Read more ››

HONG KONG, July 30, 2019 /PRNewswire/ -- Elekta Unity, a transformative magnetic resonance radiation therapy (MR/RT) system that enables personalized precision radiation therapy, is in clinical use at HKSH Cancer Centre. The milestone marks the first clinical use of Elekta Unity in Asia.